Elevance Health (ELV) Acquisitions (2010 - 2026)

Elevance Health (ELV) has 13 years of Acquisitions data on file, last reported at -$5.0 million in Q1 2026.

• On a quarterly basis, Acquisitions fell 25.0% year-over-year to -$5.0 million in Q1 2026; TTM through Jun 2026 was -$39.0 million, a 101.07% decrease from a year earlier, with the FY2025 full-year figure at -$88.0 million, down 101.83% from the prior year.
• Acquisitions for Q1 2026 stood at -$5.0 million, up from -$33.0 million in the prior quarter.
• Over the last five years, Acquisitions for ELV reached as high as $3.7 billion in Q4 2024 and fell as low as -$81.0 million in Q3 2023.
• Historically, Acquisitions has averaged $432.3 million across 5 years, with a median of $8.5 million in 2023.
• Across the five-year window, Acquisitions soared 20572.22% in 2024 and sank 1350.0% in 2025, its largest moves.
• Year by year, Acquisitions stood at $26.0 million in 2022, then tumbled by 169.23% to -$18.0 million in 2023, then surged by 20572.22% to $3.7 billion in 2024, then sank by 100.9% to -$33.0 million in 2025, then soared by 84.85% to -$5.0 million in 2026.
• Per Business Quant data, the three most recent Acquisitions figures were -$5.0 million in Q1 2026, -$33.0 million in Q4 2025, and -$1.0 million in Q3 2025.